Cancer diagnosis may be linked with improved smoking cessation
the ONA take:
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation. Little previous study research exists correlating smoking cessation with a diagnosis of cancer, though the event certainly provides the opportunity for a teachable moments in which an oncology may attempt to motivate a smoker to quit the habit.
Study author J. Lee Westmaas, PhD, and associates, based at the Behavioral Research Center, American Cancer Society, sought to determine if a link exists.
Participant data from the Cancer Prevention Study-II Nutrition Cohort was reviewed and a comparison made between the quit rates of smokers diagnosed with cancer at 2- and 4-year intervals and smokers not diagnosed with cancer. Individuals with cancers that could influence smoking (saucy as cancer of the lung or esophagus) were excluded from the review.
Both the 2-year and 4-year quit rate was found to be higher for smokers diagnosed with cancer. Even when the cancer diagnosis had a good prognosis or could not be directly linked to the smoking habit, the quit rate was found to be higher.
The investigation results suggest that a cancer diagnosis may indeed provide a teachable moment opportunity for oncology professionals.
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|